Clinical studies (SURPASS trials) have shown that tirzepatide reduces HbA1c by 1.9% to 2.4% depending on the dose, with many patients achieving HbA1c levels below 7%
Retatrutide is currently being evaluated in clinical trials, unlike tirzepatide, which is FDA-approved under the brand Zepbound for weight loss
At Affinity Whole Health, we offer compounded GLP-1 medications as a customized alternative to brand-name options
GHK-Cu is a lyophilized research peptide supplied for laboratory and analytical research purposes only
It is not a supplement you should buy from a random website and inject at home
In addition, you should tell your doctor if you: have had problems with your pancreas or kidneys have type 2 diabetes and a history of diabetic retinopathy have been depressed, suicidal or have had mental health issues are breastfeeding Wegovy is taken once a week, any time of day, with or without food